Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1994;3(2):155–160. doi: 10.1155/S0962935194000207

Endothelin-1 Stimulates Monocytes in vitro to Release Chemotactic Activity Identified as Interleukin-8 and Monocyte Chemotactic Protein-1

E Helset 1,✉, T Sildnes 1, Z S Konopski 2
PMCID: PMC2367024  PMID: 18472935

Abstract

In the present study we examined whether endothelin-1 stimulation of human monocytes causes release of chemotactic factors. It was found that monocytes released neutrophil- and monocyte-chemotactic activity in a dose- and time-dependent manner in response to ET-1. ET-1 did not show any chemotactic activity by itself. NCA was detected in monocyte supernatants in response to ET-1 (0.01–100 nM) after 1, 4, 8 and 24 h stimulation. MCA was detected only after 24 h stimulation with ET-1 (0.1–100 nM). Preincubation of the monocyte cultures with the lipoxygenase inhibitors nordihydroguaiaretic acid (10−4 M) or diethylcarbamazine (10−9 M) completely abolished the appearance of NCA and MCA. NCA was neutralized by > 75% using a polyclonal antibody against human interleuktn-8. The ET-1 induced release of IL-8 was confirmed by IL-8 ELISA. A monoclonal antibody against human monocyte chemotactic protein-1 neutralized MCA by > 80%. It is concluded that ET-1 stimulation of monocytes in vitro causes release of neutrophil- and monocyte-chemotactic activity identified as IL-8 and MCP-I respectively. An intact lipoxygenase pathway is crucial for this effect of ET-1 to occur.

Full Text

The Full Text of this article is available as a PDF (595.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrade Z. A., Reed S. G., Roters S. B., Sadigursky M. Immunopathology of experimental cutaneous leishmaniasis. Am J Pathol. 1984 Jan;114(1):137–148. [PMC free article] [PubMed] [Google Scholar]
  2. Barcinski M. A., Schechtman D., Quintao L. G., Costa D. de A., Soares L. R., Moreira M. E., Charlab R. Granulocyte-macrophage colony-stimulating factor increases the infectivity of Leishmania amazonensis by protecting promastigotes from heat-induced death. Infect Immun. 1992 Sep;60(9):3523–3527. doi: 10.1128/iai.60.9.3523-3527.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buchmüller-Rouiller Y., Betz-Corradin S., Mauël J. Differential effects of prostaglandins on macrophage activation induced by calcium ionophore A23187 or IFN-gamma. J Immunol. 1992 Feb 15;148(4):1171–1175. [PubMed] [Google Scholar]
  4. Casals-Stenzel J., Muacevic G., Weber K. H. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther. 1987 Jun;241(3):974–981. [PubMed] [Google Scholar]
  5. Chung H., Fried J., Jarabak J. Irreversible inhibition of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase/9-ketoprostaglandin reductase by glutathione thiosulfonate. Prostaglandins. 1987 Mar;33(3):391–402. doi: 10.1016/0090-6980(87)90021-9. [DOI] [PubMed] [Google Scholar]
  6. Crocker P. R., Davies E. V., Blackwell J. M. Variable expression of the murine natural resistance gene Lsh in different macrophage populations infected in vitro with Leishmania donovani. Parasite Immunol. 1987 Nov;9(6):705–719. doi: 10.1111/j.1365-3024.1987.tb00540.x. [DOI] [PubMed] [Google Scholar]
  7. Farrell J. P., Kirkpatrick C. E. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J Immunol. 1987 Feb 1;138(3):902–907. [PubMed] [Google Scholar]
  8. Goodwin J. S., Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol. 1983 Oct;3(4):295–315. doi: 10.1007/BF00915791. [DOI] [PubMed] [Google Scholar]
  9. Green S. J., Meltzer M. S., Hibbs J. B., Jr, Nacy C. A. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol. 1990 Jan 1;144(1):278–283. [PubMed] [Google Scholar]
  10. Liew F. Y., Cox F. E. Nonspecific defence mechanism: the role of nitric oxide. Immunol Today. 1991 Mar;12(3):A17–A21. doi: 10.1016/S0167-5699(05)80006-4. [DOI] [PubMed] [Google Scholar]
  11. Liew F. Y., Millott S., Parkinson C., Palmer R. M., Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol. 1990 Jun 15;144(12):4794–4797. [PubMed] [Google Scholar]
  12. Locksley R. M., Scott P. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol Today. 1991 Mar;12(3):A58–A61. doi: 10.1016/S0167-5699(05)80017-9. [DOI] [PubMed] [Google Scholar]
  13. Mauël J., Ransijn A., Buchmüller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives. J Leukoc Biol. 1991 Jan;49(1):73–82. doi: 10.1002/jlb.49.1.73. [DOI] [PubMed] [Google Scholar]
  14. Minakuchi R., Wacholtz M. C., Davis L. S., Lipsky P. E. Delineation of the mechanism of inhibition of human T cell activation by PGE2. J Immunol. 1990 Oct 15;145(8):2616–2625. [PubMed] [Google Scholar]
  15. Papadogiannakis N., Nordström T. E., Andersson L. C., Wolff C. H. cAMP inhibits the OKT3-induced increase in cytoplasmic free calcium in the Jurkat T cell line: the degree of inhibition correlates inversely with the amount of CD3 binding ligand used. Eur J Immunol. 1989 Oct;19(10):1953–1956. doi: 10.1002/eji.1830191029. [DOI] [PubMed] [Google Scholar]
  16. Poubelle P. E., Gingras D., Demers C., Dubois C., Harbour D., Grassi J., Rola-Pleszczynski M. Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes. Immunology. 1991 Feb;72(2):181–187. [PMC free article] [PubMed] [Google Scholar]
  17. Reiner N. E., Malemud C. J. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways. J Immunol. 1985 Jan;134(1):556–563. [PubMed] [Google Scholar]
  18. Reiner N. E., Malemud C. J. Arachidonic acid metabolism in murine leishmaniasis (Donovani): ex-vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells. Cell Immunol. 1984 Oct 15;88(2):501–510. doi: 10.1016/0008-8749(84)90181-3. [DOI] [PubMed] [Google Scholar]
  19. Rincón M., Tugores A., López-Rivas A., Silva A., Alonso M., De Landázuri M. O., López-Botet M. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells. Eur J Immunol. 1988 Nov;18(11):1791–1796. doi: 10.1002/eji.1830181121. [DOI] [PubMed] [Google Scholar]
  20. Scott P., James S., Sher A. The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line. Eur J Immunol. 1985 Jun;15(6):553–558. doi: 10.1002/eji.1830150605. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES